Imatinib is a revolutionary medication that has transformed the treatment of chronic myeloid leukemia (CML) and other cancers. As a targeted therapy, it selectively inhibits tyrosine kinase enzymes, disrupting cancer cell proliferation while minimizing damage to healthy cells. This advancement has significantly improved survival rates and quality of life for patients. The availability of high-quality …
Imatinib: A Breakthrough in Targeted Cancer Therapy
